AcelRx (ACRX) Briefing Docs Bode Well for Vote - H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Ed Arce reiterated a Buy rating and $7 price target on AcelRx Pharmaceuticals (NASDAQ: ACRX) said the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
